The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $130.75

Today's change+1.17 +0.90%
Updated December 24 1:04 PM EST. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $130.75

Today's change+1.17 +0.90%
Updated December 24 1:04 PM EST. Delayed by at least 15 minutes.

Edwards Lifesciences Corp crosses above 20-day moving average

Edwards Lifesciences Corp closed up Wednesday by (U.S.)$1.17 or 0.90% to (U.S.)$130.75 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.78% and are currently 2.64% off of the 52-week high. Shares have outperformed the S&P 500 by 85.70% during the last year.

Key company metrics

  • Open(U.S.) $129.76
  • Previous close(U.S.) $129.58
  • High(U.S.) $131.56
  • Low(U.S.) $129.62
  • Bid / Ask-- / --
  • YTD % change+98.83%
  • Volume247,866
  • Average volume (10-day)1,057,707
  • Average volume (1-month)1,022,211
  • Average volume (3-month)941,522
  • 52-week range(U.S.) $63.04 to (U.S.) $134.29
  • Beta0.61
  • Trailing P/E18.15×
  • P/E 1 year forward38.62×
  • Forward PEG2.61×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.20
Updated December 24 1:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+34.70%

Based on its net profit margin of 34.70%, Edwards Lifesciences Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue607575522536
Total other revenue--------
Total revenue607575522536
Gross profit439424377391
Total cost of revenue168151146146
Total operating expense487-238445435
Selling / general / administrative222216197191
Research & development88898679
Depreciation / amortization--------
Interest expense (income), net operating4455
Unusual expense (income)4-697916
Other operating expenses, total1000
Operating income12181377102
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12181377102
Income after tax955476076
Income tax, total262661726
Net income955476076
Total adjustments to net income--------
Net income before extra. items955476076
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items955476076
Inc. avail. to common incl. extra. items955476076
Diluted net income955476076
Dilution adjustment00--0
Diluted weighted average shares108107109111
Diluted EPS excluding extraordinary itemsvalue per share0.875.090.560.68
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.900.730.620.79